摘要
由于无法获得有效的治疗方法来治愈肾病,肾病的社会经济负担是巨大的。高风险患者在慢性肾病中只有两种昂贵的选择,透析和肾脏替代疗法 (RRT)。 RRT 有器官捐献者的局限性,伦理问题也与之相关。 Wnt/β-catenin 通路在生命早期的胚胎发生过程中高度保守和活跃,但在成人中受到抑制。动物研究表明,Wnt 蛋白的敲低会导致出生时肾脏发育异常。在成人肾脏中,Wnt/β-连环蛋白通路激活导致急性损伤后的组织修复,但持续激活是有害的,并会导致肾纤维化。最近,Wnt/β-catenin 信号级联已经成为成人肾脏疾病的潜在通路,被认为是开发有效治疗干预的有吸引力的治疗靶点。使用尖端分子技术获得有关特定类型 Wnt/β-catenin 通路成分参与成人肾脏疾病的精确信息将有助于开发肾脏疾病的新疗法。未来的研究将确定 Wnt/β-catenin 信号蛋白作为肾脏疾病治疗选择的有效性和安全性。
关键词: 肾脏疾病、Wnt/β-连环蛋白、信号、治疗靶点、Wnt 蛋白分泌、豪猪酶。
图形摘要
Current Drug Targets
Title:Canonical Wnt/Beta-Catenin Signaling Network as Emerging Signaling Cascade for Therapeutic Intervention in Chronic Renal Disease
Volume: 22 Issue: 16
关键词: 肾脏疾病、Wnt/β-连环蛋白、信号、治疗靶点、Wnt 蛋白分泌、豪猪酶。
摘要: The socio-economic burden of renal disease is enormous due to the unavailability of effective treatment to cure it. High risk patients have only two costly options in chronic renal disease, dialysis and renal replacement therapy (RRT). RRT has limitations of the organ donor, and ethical concerns are also associated with it. The Wnt/beta-catenin pathway is highly conserved and active during embryogenesis in early life but suppressed in adults. Animal studies suggested that knockdown of Wnt protein led to abnormal kidney development at birth. In the adult kidney, Wnt/beta-- catenin pathway activation led to tissue repair after acute injury, but sustained activation is harmful and involved in renal fibrosis. Recently, Wnt/beta-catenin signaling cascade has emerged as a potential pathway involved in adult renal diseases and is considered an attractive therapeutic target for developing effective therapeutic intervention. Precise information about the involvement of specific types of Wnt/beta-catenin pathway components in adult renal disease using cutting-edge molecular techniques will help develop novel therapies for renal diseases. Future studies will determine Wnt/beta-catenin signaling proteins' effectiveness and safety as a treatment option for renal disorders.
Export Options
About this article
Cite this article as:
Canonical Wnt/Beta-Catenin Signaling Network as Emerging Signaling Cascade for Therapeutic Intervention in Chronic Renal Disease, Current Drug Targets 2021; 22 (16) . https://dx.doi.org/10.2174/1389450122666210216092218
DOI https://dx.doi.org/10.2174/1389450122666210216092218 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Related Journals
Related Books
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Hsp20 Protects Neuroblastoma Cells from Ischemia/Reperfusion Injury by Inhibition of Apoptosis via a Mechanism that Involves the Mitochondrial Pathways
Current Neurovascular Research Cocaine Dependence and Stroke: Pathogenesis and Management
Current Neurovascular Research Flavonoids and the Brain: Evidences and Putative Mechanisms for a Protective Capacity
Current Neuropharmacology Asymmetric Dimethylarginine: Clinical Significance and Novel Therapeutic Approaches
Current Medicinal Chemistry Cell-Based Therapy to Promote Angiogenesis in the Brain Following Ischemic Damage
Current Vascular Pharmacology Sex Hormones, Metabolic Syndrome and Kidney
Current Topics in Medicinal Chemistry Resistin: An Inflammatory Cytokine. Role in Cardiovascular Diseases, Diabetes and the Metabolic Syndrome
Current Pharmaceutical Design Intranasal Fluorescent Nanocrystals for Longitudinal <i>In Vivo</i> Evaluation of Cerebral Microlesions
Pharmaceutical Nanotechnology Limiting Functional Deficiency Following Stroke: Exploiting Different Stem Cell Reservoirs
Current Neuropharmacology Myocardial Ischemia/Reperfusion Injury: Potential of TRPV1 Agonists as Cardioprotective Agents
Cardiovascular & Hematological Disorders-Drug Targets Gastric Cytoprotection Beyond Prostaglandins: Cellular and Molecular Mechanisms of Gastroprotective and Ulcer Healing Actions of Antacids
Current Pharmaceutical Design Monocytes Mediate HIV Neuropathogenesis: Mechanisms that Contribute to HIV Associated Neurocognitive Disorders
Current HIV Research Comparison of Isolation, Expansion and Cryopreservation Techniques to Produce Stem Cells from Human Exfoliated Deciduous Teeth (SHED) with Better Regenerative Potential
Current Stem Cell Research & Therapy Pulmonary Hypertension: Current Therapy and Future Prospects
Cardiovascular & Hematological Agents in Medicinal Chemistry Topical Use of Sucralfate in Epithelial Wound Healing: Clinical Evidence and Molecular Mechanisms of Action
Recent Patents on Inflammation & Allergy Drug Discovery Detection and Transport Mechanisms of Circulating microRNAs in Neurological, Cardiac and Kidney Diseases
Current Medicinal Chemistry The Role of Chinese Herbal Medicines and Bioactive Ingredients Targeting Myocardial KCa and KATP Channels in Cardiovascular Diseases
Current Pharmaceutical Design Pharmacology and Therapeutic Potential of Sigma1 Receptor Ligands
Current Neuropharmacology Targeting Leukocytes in Immune Glomerular Diseases
Current Medicinal Chemistry P-selectin Cell Adhesion Molecule in Inflammation, Thrombosis, Cancer Growth and Metastasis
Current Medicinal Chemistry